This inventor holds 1 USPTO granted patent. Top assignee: Biogen, Incorporated. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovative Contributions of Jennifer A. Lamb
Introduction
Jennifer A. Lamb is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of therapeutic methods related to actin filaments and their role in fibrin clot structure and lysis. Her innovative work has the potential to impact medical treatments and diagnostics.
Latest Patents
Jennifer holds a patent titled "Effects of actin filaments of fibrin clot structure and lysis." This invention relates to therapeutic methods wherein an actin-binding protein, preferably gelsolin or DBP, is administered to a patient with actin-containing clots in order to remove actin from the clots. The invention also encompasses diagnostic methods in which actin is removed from an actin-containing clot in vitro and quantitated. She has 1 patent to her name.
Career Highlights
Jennifer A. Lamb is currently associated with Biogen, Incorporated, where she continues to advance her research and innovations. Her work is crucial in understanding the complexities of actin in clot formation and dissolution.
Collaborations
Jennifer has collaborated with notable colleagues such as Paul A. Janmey and Stuart E. Lind, enhancing the scope and impact of her research.
Conclusion
Jennifer A. Lamb's contributions to the field of therapeutic methods for actin-containing clots demonstrate her innovative spirit and dedication to advancing medical science. Her work is paving the way for new diagnostic and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile